SI Prada, E Pulgarín-Rodríguez… - Journal of Immigrant and …, 2023 - Springer
Background There is no characterization of resource use in the hospital setting for immigrants in Colombia, we aimed to describe the resource use by Venezuelan immigrants …
S Schmitz, M Vaillant, C Renoux, RL Konsbruck… - PharmacoEconomics …, 2022 - Springer
Background Parkinson's disease (PD) is the second most common neurodegenerative disorder, with an increasing prevalence worldwide. Estimates of the economic burden …
Introduction. Parkinson's disease (PD) is one of the most prevalent age‐related neurodegenerative disorders. The progression of PD produces an important disease burden …
AM Vidal, JMC Prieto, AR Meza - Revista Científica de Salud y …, 2024 - revistavitalia.org
Introducción La ansiedad es una presentación sintomática no motora de la Enfermedad de Parkinson (EP), condición neurodegenerativa de aparición en los adultos, considerada …
Results. A total of 3,224 patients (51.8% men) with a mean age of 73.1±13.5 years started treatment with antiparkinsonian agents. After five years, 2,046 patients (63.5%) had …
A Valencia-Vásquez, A Gaviria-Mendoza… - Revista de …, 2023 - ncbi.nlm.nih.gov
Resultados. Un total de 3.224 pacientes (51, 8%, hombres), con edad media de 73, 1±13, 5 años, iniciaron tratamiento con fármacos antiparkinsonianos. Después de cinco años, 2.046 …
La enfermedad de Parkinson (EP), es un trastorno neurodegenerativo incurable heterogéneo, frecuente, cuya prevalencia aumenta con la edad1. Se caracteriza por …
Background: Parkinson's disease (PD) is one of the most common neurological chronic diseases among older adults in Canada. More than 100,000 Canadians are diagnosed with …
Introduction. Parkinson's disease (PD) is one of the most prevalent age-related neurodegenerative disorders. e progression of PD produces an important disease burden in …